Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary M Horowitz

Showing results (41-50 of 260) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|April 27, 2007
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemiaSergio A Giralt, Mukta Arora, John M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2018
Patient HLA Germline Variation and Transplant SurvivorshipEffie W Petersdorf, Philip Stevenson, Mari Malkki, et al.
Blood|October 8, 2010
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioningNavneet S Majhail, Ruta Brazauskas, J Douglas Rizzo, et al.
Journal of Pediatric Hematology/Oncology|June 21, 2018
Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell TransplantationNeel S Bhatt, Ruta Brazauskas, Heather R Tecca, et al.
Blood|September 2, 2006
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationNorbert Schmitz, Mary Eapen, Mary M Horowitz, et al.
The New England Journal of Medicine|August 13, 2015
High HLA-DP Expression and Graft-versus-Host DiseaseEffie W Petersdorf, Mari Malkki, Colm O'hUigin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantationMary Eapen, Brent R Logan, Mary M Horowitz, et al.
Blood|June 17, 2004
Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantationStephanie J Lee, Steven Joffe, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseMarcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Factors associated with self-reported physical and mental health after hematopoietic cell transplantationJohn R Wingard, I-Chan Huang, Kathleen A Sobocinski, et al.
Pageof 26

Showing results (41-50 of 260) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|April 27, 2007
Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemiaSergio A Giralt, Mukta Arora, John M Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2018
Patient HLA Germline Variation and Transplant SurvivorshipEffie W Petersdorf, Philip Stevenson, Mari Malkki, et al.
Blood|October 8, 2010
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioningNavneet S Majhail, Ruta Brazauskas, J Douglas Rizzo, et al.
Journal of Pediatric Hematology/Oncology|June 21, 2018
Female Sex is Associated With Poor Health-related Quality of Life in Children at 12 Months Post-Hematopoietic Cell TransplantationNeel S Bhatt, Ruta Brazauskas, Heather R Tecca, et al.
Blood|September 2, 2006
Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationNorbert Schmitz, Mary Eapen, Mary M Horowitz, et al.
The New England Journal of Medicine|August 13, 2015
High HLA-DP Expression and Graft-versus-Host DiseaseEffie W Petersdorf, Mari Malkki, Colm O'hUigin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2014
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantationMary Eapen, Brent R Logan, Mary M Horowitz, et al.
Blood|June 17, 2004
Physicians' attitudes about quality-of-life issues in hematopoietic stem cell transplantationStephanie J Lee, Steven Joffe, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 16, 2010
Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial responseMarcie R Tomblyn, Marian Ewell, Christopher Bredeson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Factors associated with self-reported physical and mental health after hematopoietic cell transplantationJohn R Wingard, I-Chan Huang, Kathleen A Sobocinski, et al.
Pageof 26